Coiffier, Bertrand <br/><br/>
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study.  [electronic resource] 

 -  British journal of haematology  Jul 2010 
 - 58-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2010.08193.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antigens, CD20--immunology<br/>Antineoplastic Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Leukemia, Lymphocytic, Chronic, B-Cell--blood<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Recurrence<br/>Survival Analysis<br/>Treatment Outcome